Note: this is second in a two-part series aimed not only at patients, but those in the Pharma industry as well.I was interviewed the other day for an upcoming story about Sanofi-Aventis’ new strategy to not just offer individual diabetes product…
SOURCE: Healthline RSS Feed – Read entire story here.